相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Nanobodies in Human Infections: Prevention, Detection, and Treatment
Marzieh Sanaei et al.
IMMUNOLOGICAL INVESTIGATIONS (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Race to find COVID-19 treatments accelerates
Kai Kupferschmidt et al.
SCIENCE (2020)
Fast, portable tests come online to curb coronavirus pandemic
Cormac Sheridan
NATURE BIOTECHNOLOGY (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies (vol 181, pg 1004, 2020)
Daniel Wrapp et al.
CELL (2020)
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiangdong Huo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development
Sayeh Ezzikouri et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
Leo Hanke et al.
NATURE COMMUNICATIONS (2020)
Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix
Noor Jailkhani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
Guangyu Zhao et al.
JOURNAL OF VIROLOGY (2018)
Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection
V. Stalin Raj et al.
SCIENCE ADVANCES (2018)
Single-Domain Antibodies and Their Formatting to Combat Viral Infections
Dorien De Vlieger et al.
ANTIBODIES (2018)
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Laurent Detalle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Nebulization as a delivery method for mAbs in respiratory diseases
Renaud Respaud et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
Nanobodies as modulators of inflammation: potential applications for acute brain injury
Bjoern Rissiek et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection
Lorena Itati Ibanez et al.
JOURNAL OF INFECTIOUS DISEASES (2011)